enVVeno Medical Corporation (NVNO) vs Soligenix, Inc. (SNGX)
A side-by-side comparison of enVVeno Medical Corporation and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NVNO
enVVeno Medical Corporation
$8.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SNGX
Soligenix, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NVNO vs SNGX
growth of $100 · dividends reinvested · last 8yNVNO -99.8% (-54.9%/yr)SNGX -99.9% (-57.9%/yr)NVNO compounded faster over this window
NVNO SNGX
NVNO vs SNGX: by the numbers
- •NVNO is the larger company ($6M vs $5M market cap).
Metrics side by side
Valuation
| Metric | NVNO | SNGX |
|---|---|---|
| P/B ratio | 0.28 | 0.80 |
Profitability
| Metric | NVNO | SNGX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -76.07% | -154.08% |
| ROIC | -80.65% | -161.69% |
Growth (annualized)
| Metric | NVNO | SNGX |
|---|---|---|
| Total return CAGR (5Y) | -52.99% | -72.72% |
Frequently asked
- How have NVNO and SNGX total returns compared?
- Over the past 5 years, NVNO delivered -52.99% and SNGX delivered -72.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.